Timken Company
TKR
$110.56
+1.25%
The Timken Company designs, manufactures, and services a portfolio of engineered bearings and industrial motion products — including tapered roller bearings, housed bearings, linear guides, lubrication systems, couplings, brakes, and seals — sold under brands such as Timken, GGB, Philadelphia Gear, Cone Drive, CGI, and Rollon, with roughly 64% of revenue from the Engineered Bearings segment and the balance from Industrial Motion. As one of the oldest and most recognized names in precision bearings, Timken occupies a premium, specification-driven position in global industrial motion, competing on engineering quality and aftermarket service rather than price, and its 19,000 employees and 415-consecutive-quarter dividend record reinforce its identity as a durable, cyclical industrial compounder. The current investor debate centers on whether the company can sustain its recent margin recovery — Q3 2026 gross margin of 31.9% and operating margin of 13.7% marked a clear step up from the 21.9% gross margin trough in Q4 2025 — against a backdrop of soft industrial demand, tariff and input-cost pressure, and a stock that has given back a large portion of its earlier 2026 gains. Sentiment has been whipsawed: a solid Q2 beat with raised guidance was followed by an 8.5% post-earnings decline on sector headwinds and downward estimate revisions, and the shares fell sharply again in early November after Q3 results, leaving investors weighing long-cycle aftermarket resilience and self-help cost actions against near-term cyclical risk.…
TKR
Timken Company
$110.56
Related headlines
Investment Opinion: Should I buy TKR Today?
Rating: Hold with a constructive, accumulation-biased tilt. The core thesis is that Timken is a high-quality, specification-driven industrial franchise trading at a cyclical discount — 13.93x forward earnings and 1.28x sales — but the near-term evidence (a fresh 180-day low at $99.94 on November 5, a 21.71% three-month decline, and estimates being cut faster than ratings) argues against chasing the stock before the cycle inflects. The analyst consensus of "buy" (7 Buy, 5 Hold, 0 Sell; mean score 2.0) and an average target of $141.38 imply 38.6% upside, but that gap reflects how far the shares have fallen below Street models rather than fresh conviction, so the rating is anchored to valuation support rather than momentum.
Supporting evidence is genuinely two-sided but tilts modestly positive on a 12-month view. Valuation is the strongest pillar: 13.93x forward PE versus 20.37x trailing represents 31.6% compression, and the 1.28x PS, 1.83x EV/Sales, 10.27x EV/EBITDA, and 1.84x P/B all sit well below the 5–8x PS and 33–57x EV/EBITDA readings recorded during 2025–2026. Profitability has recovered materially — Q3 2026 gross margin of 31.9% versus the 21.9% Q4 2025 trough and 30.2% in Q3 2025, with operating margin of 13.7% and net income of $93.8 million — and TTM free cash flow of $443.1 million yields roughly 7.5% against the $5.87 billion market cap, comfortably covering the 1.67% dividend at a 34.1% payout. The offset is that revenue growth of only 4.69% year-over-year and a 3.9% sequential decline from Q2's $1.2609 billion show the volume recovery embedded in consensus 2027 revenue of $5.22 billion has not yet appeared.
Three risks could invalidate the thesis: (1) gross margin slipping back toward the high-20s, which would collapse the forward EPS bridge to $8.55 and make the 13.9x forward multiple illusory; (2) a prolonged industrial slowdown that keeps volumes flat and forces target cuts from $141.38 toward the $120 low; and (3) leverage — debt-to-equity of 0.677 and interest coverage of just 6.4x leave limited cushion, with quarterly FCF already swinging from $0.5 million in Q1 2026 to $221.4 million in Q3. This Hold would upgrade to Buy on a decisive reclaim of $120 with gross margin holding above 31%, or on forward EPS estimates stabilizing above $8.00; it would downgrade to Sell on a break below the $99.94 support accompanied by gross margin falling below 29%. Verdict: fairly valued to modestly undervalued relative to history and peers, but not yet a confirmed bargain until the cycle shows its hand.
Sign up to view all
TKR 12-Month Price Forecast
Timken presents a classic cyclical value setup where the valuation is compelling but the timing is unresolved. At 13.93x forward earnings and 1.28x sales — near the bottom of its multi-year PS range — the market is pricing margin normalization risk rather than a revenue shock, and the gross margin recovery from 21.9% to 31.9% shows the operating leverage is real. Against that, momentum is decisively negative with a fresh 180-day low at $99.94, a 21.71% three-month decline, and 16.80 points of three-month underperformance versus SPY, while estimates are being trimmed faster than ratings. The 38.6% upside to the $141.38 average target is unusually wide and reflects how far the shares have fallen below Street models rather than fresh bullish conviction. I would upgrade to bullish on a decisive reclaim of $120 with gross margin holding above 31%, and downgrade to bearish on a break below $99.94 accompanied by gross margin slipping below 29%.
Wall Street consensus
Coverage is solid for a mid-cap industrial: 11 analysts with a distribution of 7 Buy, 5 Hold, and 0 Sell, yielding a consensus recommendation of "buy" (mean score 2.0). The average target price of $141.38 implies roughly 38.6% upside from the current $102.03 — an unusually wide gap that reflects how far the shares have fallen below where the Street's models sit rather than fresh bullish conviction. Consensus 2027 EPS of $8.55 and revenue of $5.22 billion underpin those targets, and the bullish tilt is notable given the stock's 21.7% three-month decline.
The target range of $120.00 to $160.00 is wide — a 33% spread from low to high — signaling genuine disagreement about the cycle. The $160 high case assumes multiple expansion back toward 18–20x forward EPS plus a volume recovery in Engineered Bearings and Industrial Motion; the $120 low case still implies 17.6% upside and effectively prices in margin compression and a prolonged industrial slowdown without a recession. Institutional actions skew constructive: B of A Securities upgraded to Buy from Neutral on September 1, 2026, while Citigroup, Oppenheimer, Evercore ISI, JP Morgan, and KeyBanc have reiterated Buy/Outperform/Overweight ratings through November 5, with Goldman Sachs the notable Neutral holdout. The pattern of reiterated (rather than fresh) bullish ratings alongside a falling stock price suggests estimates are being trimmed faster than ratings — a setup that often precedes either a capitulation low or a round of target cuts.
Bulls vs Bears: TKR Investment Factors
The bear case currently has stronger near-term evidence: momentum is decisively negative with a fresh 180-day low, revenue growth of 4.69% is decelerating sequentially, and estimates are being cut faster than ratings. The bull case rests on valuation and mean reversion — a 13.93x forward PE, 1.28x PS near multi-year lows, 38.6% implied upside to the $141.38 average target, and a genuine gross margin recovery from 21.9% to 31.9%. The single most important tension is whether the forward EPS bridge to $8.55 materializes: if margins hold near 32% and industrial volumes recover, the stock is deeply undervalued; if the cycle stalls, the trailing 20.4x multiple is full and the $99.94 support likely breaks toward the mid-$90s. With beta of 1.178 amplifying any macro move, this is a high-conviction call in either direction rather than a neutral setup.
Bullish
- Forward PE compression signals deep value: TKR trades at 20.37x trailing but only 13.93x forward earnings, a 31.6% compression that implies the market expects EPS to climb from roughly $5.01 to about $7.32. Consensus 2027 EPS of $8.55 would make the forward multiple even cheaper, and the 1.28x PS ratio sits near the bottom of its multi-year range versus 4.3-8.0x historically.
- Analyst targets imply 38.6% upside: The average target of $141.38 versus the $102.03 price implies 38.6% upside, and even the $120 low target implies 17.6% upside. With 7 Buy, 5 Hold, and 0 Sell ratings and a mean score of 2.0, the Street remains constructive despite the 21.7% three-month decline.
- Gross margin recovery is real: Q3 2026 gross margin of 31.9% marked a clear step up from the 21.9% trough in Q4 2025 and exceeded the 30.2% posted in Q3 2025. Operating margin of 13.7% and net income of $93.8 million confirm the recovery is flowing through to the bottom line after Q2's $108.6 million other-expense distortion.
- Strong FCF and dividend durability: TTM free cash flow of $443.1 million against a $5.87 billion market cap yields roughly 7.5%, comfortably covering the 1.67% dividend yield at a 34.1% payout ratio. The 415-consecutive-quarter dividend record and Q3 operating cash flow of $256.1 million funding capex, dividends, and $63.8 million of buybacks underscore self-funding capacity.
Bearish
- Momentum has decisively broken down: TKR is down 11.21% over one month and 21.71% over three months, underperforming SPY by 6.22 and 16.80 percentage points respectively. The November 5 close of $99.94 was a fresh 180-day low, and the 6-month decline of 13.51% shows the trailing-year gain of 30.89% is being steadily eroded.
- Revenue trajectory is uneven and decelerating: Q3 2026 revenue of $1.2114 billion grew only 4.69% year-over-year and fell 3.9% sequentially from Q2's $1.2609 billion. Consensus 2027 revenue of $5.22 billion implies mid-single-digit growth, meaning the thesis depends on a volume recovery that has not yet appeared in the order book.
- Leverage limits downturn cushion: Debt-to-equity of 0.677 and $25.8 million of quarterly interest expense produce thin interest coverage of 6.4x, leaving limited room in a deep cyclical downturn. Quarterly FCF has been volatile, swinging from just $0.5 million in Q1 2026 on a $125.7 million working-capital drain to $221.4 million in Q3.
- Estimates being cut faster than ratings: The pattern of reiterated rather than fresh Buy ratings alongside a falling stock price suggests estimates are being trimmed faster than ratings, a setup that often precedes a round of target cuts. The stock fell 8.5% after a solid Q2 beat and raised guidance, and dropped sharply again after Q3 results.
TKR Technical Analysis
Timken is in a clear intermediate downtrend within a still-positive longer-term structure. The stock is up 30.89% over the past year and 18.24% year-to-date, but at $102.03 it sits just 26.4% above its 52-week low of $73.62 and 30.3% below its 52-week high of $146.37 — roughly 39% of the way up the 52-week range, which places it in the lower-middle of the band and signals that momentum has decisively shifted from the highs rather than that the stock is near an overextended peak. The 31.23% maximum drawdown confirms the market has already de-risked a meaningful portion of the prior advance.
Short-term momentum is sharply negative and diverging from the 1-year trend. The stock is down 11.21% over the past month and 21.71% over three months, versus a still-positive 30.89% 1-year return and a 6-month decline of 13.51% — a classic deceleration pattern in which the trailing-year gain is being steadily eroded. Relative strength tells the same story: TKR has underperformed SPY by 6.22 percentage points over 1 month and 16.80 points over 3 months, even as it retains a 21.30-point 1-year relative advantage. The most recent session did bounce 2.09% off the prior close of $99.94, and the November 5 close of $99.94 marked a fresh low for the 180-day window, so the rebound is occurring from oversold territory rather than from strength; the short ratio of 5.23 days-to-cover also hints at meaningful bearish positioning that could fuel squeezes on any positive catalyst.
Key technical levels are well defined. Support sits at the $99.94 recent low, with the 52-week low of $73.62 as the deeper floor; resistance is anchored at the 52-week high of $146.37, with intermediate supply likely in the $120–$130 zone where the stock traded heavily in August and September. A decisive break below $99.94 would confirm the downtrend and open the door toward the mid-$90s, while reclaiming $120 would signal the correction has run its course. With a beta of 1.178, Timken is roughly 18% more volatile than the market — meaningful for position sizing, since a 10% SPY drawdown would historically imply a ~12% move in TKR, and the current 31.23% peak-to-trough drawdown illustrates that cyclical amplification in practice.
Beta
—
—
Max Drawdown
-31.2%
Largest decline past year
52-Week Range
—
Price range past year
Annual Return
+41.4%
Cumulative gain past year
| Period | TKR Return | S&P 500 |
|---|---|---|
| 1m | -4.0% | -2.4% |
| 3m | -15.8% | -2.3% |
| 6m | -3.4% | +2.8% |
| 1y | +41.4% | +11.3% |
| ytd | +28.1% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
TKR Fundamental Analysis
Revenue is growing modestly but the trajectory is uneven. Q3 2026 revenue of $1.2114 billion rose 4.69% year-over-year versus $1.1571 billion in Q3 2025, and the sequential path — $1.2313 billion in Q1, $1.2609 billion in Q2, $1.2114 billion in Q3 — shows a mid-year peak followed by a sequential decline of about 3.9%. Engineered Bearings generated $771.4 million (63.7% of segment revenue) versus $440.0 million for Industrial Motion, so the bearings franchise remains the swing factor for the consolidated top line. The 4.69% growth rate is respectable for a mature industrial but well below what the analyst community models: consensus 2027 revenue of roughly $5.22 billion implies mid-single-digit expansion, meaning the investment case depends on volume recovery rather than rapid share gains.
Profitability is solid and has improved materially off the trough. Q3 2026 net income was $93.8 million on a 31.9% gross margin and 13.7% operating margin, with net margin of 7.74% — a sharp recovery from Q2's $28.9 million of net income, 31.7% gross margin, and 2.29% net margin, which was distorted by $108.6 million of other expenses. The Q4 2025 quarter was the low point at a 21.9% gross margin and 5.61% net margin, so the year-over-year gross margin comparison (31.9% vs. 30.2% in Q3 2025) confirms genuine expansion. Trailing net margin of 6.29% and operating margin of 12.35% are reasonable for a capital-intensive bearing manufacturer, though the 28.7% trailing gross margin remains below the 31–32% levels achieved in 2023–2024, leaving room for further recovery.
Balance-sheet and cash-flow quality are adequate but not fortress-like. Debt-to-equity is 0.677, the current ratio is a healthy 2.82, and TTM free cash flow is $443.1 million against a $5.87 billion market cap — a roughly 7.5% FCF yield that comfortably covers the 1.67% dividend yield (payout ratio 34.1%). ROE of 9.06% and ROA of 6.00% are modest, reflecting a 2.10x equity multiplier, and quarterly FCF has been volatile ($221.4 million in Q3 2026 versus just $0.5 million in Q1 2026 on a $125.7 million working-capital drain). The company is self-funding — Q3 operating cash flow of $256.1 million covered $34.7 million of capex, $24.9 million of dividends, and $63.8 million of buybacks — but the thin interest coverage of 6.4x and $25.8 million quarterly interest expense mean leverage leaves limited room for a deep cyclical downturn.
Quarterly Revenue
$1.2B
2026-09
Revenue YoY Growth
+4.7%
YoY Comparison
Gross Margin
31.9%
Latest Quarter
Free Cash Flow
$443100000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is TKR Overvalued?
Because Timken is profitable (Q3 2026 net income of $93.8 million; trailing EPS positive), the PE ratio is the appropriate primary metric. The stock trades at 20.37x trailing earnings but only 13.93x forward earnings — a 31.6% compression that implies the market expects EPS to grow from roughly $5.01 trailing to about $7.32 forward, consistent with consensus 2027 EPS of $8.55. That gap is the crux of the debate: investors are being asked to look through a soft patch to a recovery that has not yet appeared in the order book.
On the secondary multiples, TKR screens cheap relative to its own history and to industrial peers. The PS ratio of 1.28x, EV/Sales of 1.83x, EV/EBITDA of 10.27x, and P/B of 1.84x are all well below the 5–8x PS and 33–57x EV/EBITDA readings recorded in the historical ratios table during 2025–2026, when the stock traded at much higher prices. The 1.28x sales multiple is low for a branded, specification-driven industrial with a 31.9% gross margin, though the negative PEG ratio of -1.15 reflects the earnings trough rather than a genuine growth discount. On a peer basis, 10.3x EV/EBITDA is roughly in line with diversified industrial machinery averages, suggesting the discount is cyclical rather than structural.
Historically, the current 20.37x trailing PE sits in the middle of the 12–24x band the stock has occupied since 2022, but the 1.28x PS is near the bottom of its multi-year range (versus 4.3–8.0x in the historical table) — a discrepancy driven by the collapse in the share price rather than by deteriorating sales. That combination implies the market is pricing in margin normalization risk rather than a revenue shock; if gross margins continue recovering toward the 31–32% range and forward EPS of $8.55 is delivered, the 13.9x forward multiple would represent a meaningful value opportunity, whereas failure to hit that number would leave the trailing 20.4x looking full.
PE
20.4x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 9x~24x
vs. Industry Avg
23.5x
Industry PE ~23.5x*
EV/EBITDA
10.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on leverage and earnings volatility. Debt-to-equity of 0.677 and $25.8 million of quarterly interest expense yield interest coverage of just 6.4x, leaving limited cushion in a downturn, while quarterly free cash flow swung from $0.5 million in Q1 2026 (on a $125.7 million working-capital drain) to $221.4 million in Q3. Revenue concentration is significant: Engineered Bearings generated $771.4 million, or 63.7% of segment revenue, making the bearings franchise the swing factor for the consolidated top line. ROE of 9.06% and ROA of 6.00% are modest for a capital-intensive manufacturer, and the 28.7% trailing gross margin remains below the 31-32% achieved in 2023-2024, so further recovery is needed to justify forward estimates. Market and competitive risks stem from cyclicality and valuation sensitivity. Beta of 1.178 means a 10% SPY drawdown would historically imply roughly a 12% move in TKR, and the 31.23% peak-to-trough drawdown illustrates that amplification in practice. The stock has underperformed SPY by 16.80 percentage points over three months, and the 8.5% post-Q2 decline despite a beat and raised guidance shows the market is punishing industrial cyclicals on sector headwinds and downward estimate revisions. Tariff and input-cost pressure, plus soft industrial demand, threaten the margin recovery that underpins the 13.93x forward multiple; if gross margins slip back toward the high-20s, the forward EPS bridge to $8.55 collapses. The worst-case scenario is a prolonged industrial slowdown without recession that keeps volumes flat, compresses gross margin back toward the 21.9% Q4 2025 trough, and forces analysts to cut the $141.38 average target toward the $120 low. In that chain, the stock would retest and likely break the $99.94 support, with the 52-week low of $73.62 as the deeper floor — a decline of roughly 28% from the current $102.03. A more severe outcome combining a macro contraction with leverage concerns could approach that $73.62 level, implying downside of about 28%, while the already-realized 31.23% max drawdown shows this magnitude is historically plausible for TKR.
FAQ
Ranked by severity: first, earnings/margin risk — gross margin could revert from 31.9% toward the 21.9% Q4 2025 trough on tariff and input-cost pressure, which would collapse the forward EPS bridge to $8.55 and invalidate the 13.93x forward multiple. Second, cyclical demand risk — revenue grew only 4.69% year-over-year and fell 3.9% sequentially from Q2's $1.2609 billion, and Engineered Bearings at 63.7% of segment revenue makes the bearings franchise the single swing factor for the top line. Third, leverage and cash-flow volatility — debt-to-equity of 0.677 and interest coverage of just 6.4x leave thin cushion, with quarterly free cash flow swinging from $0.5 million in Q1 2026 to $221.4 million in Q3. Fourth, market/valuation risk — beta of 1.178 means a 10% SPY decline historically implies roughly a 12% move in TKR, and the stock has already absorbed a 31.23% max drawdown.
The base case (50% probability) targets $115–$141, assuming mid-single-digit revenue growth near the 4.69% Q3 rate, gross margin in the 30–32% band, and delivery of the $8.55 forward EPS, with the stock partially closing the gap to the $141.38 average target. The bull case (30%) targets $141–$160 on industrial volume recovery, gross margin holding near 32%, and multiple expansion toward 18–20x forward earnings. The bear case (20%) targets $74–$100 if margin reverts toward the 21.9% trough and targets are cut toward the $120 low, breaking the $99.94 support and retesting the $73.62 52-week low. The base case is most likely, and its key assumption is that gross margin stays above 30% while forward EPS estimates hold near $8.55.
On the primary metric, TKR looks undervalued on forward earnings: 13.93x forward PE versus 20.37x trailing is a 31.6% compression that implies EPS rising from roughly $5.01 to about $7.32, and consensus 2027 EPS of $8.55 would make it cheaper still. Secondary multiples reinforce the discount — 1.28x PS, 1.83x EV/Sales, 10.27x EV/EBITDA, and 1.84x P/B all sit well below the 5–8x PS and 33–57x EV/EBITDA readings recorded during 2025–2026. However, the 20.37x trailing PE sits mid-range versus the 12–24x band since 2022, and the negative PEG of -1.15 reflects an earnings trough rather than a genuine growth discount. The market is pricing margin normalization risk, not a revenue shock; if the $8.55 EPS bridge is delivered the stock is meaningfully undervalued, and if it is not, the trailing multiple looks full.
The risk/reward is asymmetric but unconfirmed. Upside to the $141.38 average analyst target is 38.6% from $102.03, and even the $120 low target implies 17.6% upside, while the realistic downside to the $73.62 52-week low is roughly 28% — a favorable ratio on paper. The catch is that the upside depends on delivering consensus 2027 EPS of $8.55, which requires gross margin to hold near 32% and industrial volumes to recover from a 4.69% growth rate that actually decelerated 3.9% sequentially in Q3. Momentum is against buyers: the stock hit a fresh 180-day low of $99.94 on November 5 and has underperformed SPY by 16.80 points over three months. It is a good buy for value-oriented investors with a 12–24 month horizon who accumulate in tranches near the $100 support, but not for momentum traders or anyone needing near-term earnings visibility.
TKR is better suited to a medium-to-long-term holding than short-term trading. It is a mature, capital-intensive industrial with 4.69% revenue growth, modest ROE of 9.06% and ROA of 6.00%, and earnings visibility that depends on an industrial cycle not yet confirmed — so the 13.93x forward multiple needs time to be validated by the $8.55 EPS bridge. Volatility argues against short horizons: beta of 1.178, a 31.23% max drawdown, and a 21.71% three-month decline mean a trader could be stopped out before the cycle inflects. The 1.67% dividend yield at a 34.1% payout and the 415-consecutive-quarter dividend record reward patience but are not large enough to anchor an income strategy. A minimum holding period of 12–24 months is appropriate, with position sizing that accounts for roughly 18% more volatility than the market.